Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taurocholic acid is a naturally occurring bile acid formed by the conjugation of cholic acid with taurine. It is a major component of bile in many mammals and plays an essential role in the emulsification and absorption of dietary fats and fat-soluble vitamins in the intestine. Taurocholic acid acts as a detergent to solubilize lipids for digestion and absorption. Pharmacologically, it has been investigated as an agonist of GPBAR1 (also known as TGR5), a G protein-coupled bile acid receptor involved in glucose metabolism and energy homeostasis. Taurocholic acid has been studied for potential therapeutic use in metabolic diseases such as obesity and type 2 diabetes mellitus; however, clinical development for these indications was discontinued[1][3][5][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on taurocholic acid.